Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Optimizing Platelet GPVI Inhibition versus Haemostatic Impairment by the Btk Inhibitors Ibrutinib, Acalabrutinib, ONO/GS-4059, BGB-3111 and Evobrutinib.

Denzinger V, Busygina K, Jamasbi J, Pekrul I, Spannagl M, Weber C, Lorenz R, Siess W.

Thromb Haemost. 2019 Mar;119(3):397-406. doi: 10.1055/s-0039-1677744. Epub 2019 Jan 27.

PMID:
30685871
2.

Oral Bruton tyrosine kinase inhibitors selectively block atherosclerotic plaque-triggered thrombus formation in humans.

Busygina K, Jamasbi J, Seiler T, Deckmyn H, Weber C, Brandl R, Lorenz R, Siess W.

Blood. 2018 Jun 14;131(24):2605-2616. doi: 10.1182/blood-2017-09-808808. Epub 2018 Mar 20.

PMID:
29559479
3.

Dimeric Glycoprotein VI Binds to Collagen but Not to Fibrin.

Ebrahim M, Jamasbi J, Adler K, Megens RTA, M'Bengue Y, Blanchet X, Uhland K, Ungerer M, Brandl R, Weber C, Elia N, Lorenz R, Münch G, Siess W.

Thromb Haemost. 2018 Feb;118(2):351-361. doi: 10.1160/TH17-04-0302. Epub 2018 Jan 29.

PMID:
29378359
4.

ADPase CD39 Fused to Glycoprotein VI-Fc Boosts Local Antithrombotic Effects at Vascular Lesions.

Degen H, Borst O, Ziegler M, Mojica Munoz AK, Jamasbi J, Walker B, Göbel S, Fassbender J, Adler K, Brandl R, Münch G, Lorenz R, Siess W, Gawaz M, Ungerer M.

J Am Heart Assoc. 2017 Jul 27;6(8). pii: e005991. doi: 10.1161/JAHA.117.005991.

5.

Platelet receptors as therapeutic targets: Past, present and future.

Jamasbi J, Ayabe K, Goto S, Nieswandt B, Peter K, Siess W.

Thromb Haemost. 2017 Jun 28;117(7):1249-1257. doi: 10.1160/TH16-12-0911. Epub 2017 Jun 9. Review.

PMID:
28597906
6.

Recombinant GPVI-Fc added to single or dual antiplatelet therapy in vitro prevents plaque-induced platelet thrombus formation.

Mojica Muñoz AK, Jamasbi J, Uhland K, Degen H, Münch G, Ungerer M, Brandl R, Megens R, Weber C, Lorenz R, Siess W.

Thromb Haemost. 2017 Aug 1;117(8):1651-1659. doi: 10.1160/TH16-11-0856. Epub 2017 Jun 1.

PMID:
28569920
7.

Oral thrombin inhibitor aggravates platelet adhesion and aggregation during arterial thrombosis.

Petzold T, Thienel M, Konrad I, Schubert I, Regenauer R, Hoppe B, Lorenz M, Eckart A, Chandraratne S, Lennerz C, Kolb C, Braun D, Jamasbi J, Brandl R, Braun S, Siess W, Schulz C, Massberg S.

Sci Transl Med. 2016 Nov 30;8(367):367ra168.

PMID:
27903864
8.

Cross-Linking GPVI-Fc by Anti-Fc Antibodies Potentiates Its Inhibition of Atherosclerotic Plaque- and Collagen-Induced Platelet Activation.

Jamasbi J, Megens RT, Bianchini M, Uhland K, Münch G, Ungerer M, Sherman S, Faussner A, Brandl R, John C, Buchner J, Weber C, Lorenz R, Elia N, Siess W.

JACC Basic Transl Sci. 2016 Apr 25;1(3):131-142.. eCollection 2016 Apr. Review.

9.

Cathepsin G Controls Arterial But Not Venular Myeloid Cell Recruitment.

Ortega-Gomez A, Salvermoser M, Rossaint J, Pick R, Brauner J, Lemnitzer P, Tilgner J, de Jong RJ, Megens RT, Jamasbi J, Döring Y, Pham CT, Scheiermann C, Siess W, Drechsler M, Weber C, Grommes J, Zarbock A, Walzog B, Soehnlein O.

Circulation. 2016 Oct 18;134(16):1176-1188. Epub 2016 Sep 22.

10.

Differential Inhibition of Human Atherosclerotic Plaque-Induced Platelet Activation by Dimeric GPVI-Fc and Anti-GPVI Antibodies: Functional and Imaging Studies.

Jamasbi J, Megens RT, Bianchini M, Münch G, Ungerer M, Faussner A, Sherman S, Walker A, Goyal P, Jung S, Brandl R, Weber C, Lorenz R, Farndale R, Elia N, Siess W.

J Am Coll Cardiol. 2015 Jun 9;65(22):2404-15. doi: 10.1016/j.jacc.2015.03.573.

11.

Stereo specific platelet inhibition by the natural LXR agonist 22(R)-OH-cholesterol and its fluorescence labelling with preserved bioactivity and chiral handling in macrophages.

Schaffer S, Tandon R, Zipse H, Siess W, Schmidt A, Jamasbi J, Karshovska E, Steglich W, Lorenz R.

Biochem Pharmacol. 2013 Jul 15;86(2):279-85. doi: 10.1016/j.bcp.2013.04.024. Epub 2013 May 9.

PMID:
23665353

Supplemental Content

Loading ...
Support Center